Byline: Kristin Samuelson
-
Diabetes Drug Metformin Shows Potential Benefit in Large COVID-19 Trial
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
-
Bigger is Better for Genetic Tests That Check for Cardiomyopathy, Arrhythmias
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
-
Twitter Health Amplifiers Combat COVID-19 Misinformation
Physicians and scientists from Northwestern Medicine and other institutions have banded together to combat COVID-19 misinformation and disinformation.
-
Most Common Lung Function Test Misses Lung Disease in Many Black U.S. Adults
The most common test to measure a person’s lung function may be missing many people with impaired lung health, according to a new study.
-
First-Ever Millennial Lung Health Study Launches in Chicago Amid COVID-19
Northwestern and the American Lung Association have begun a first-of-its-kind longitudinal study to track and analyze the lungs of millennials at the peak of their lung health.
-
Almost Half of Heart Failure Patients Have Uncontrolled Hypertension and Diabetes
A new Northwestern Medicine study has found almost half of U.S. adults with heart failure have poorly controlled hypertension and diabetes.
-
New Course Preps Medical Students for the Next Disaster
Feinberg students are being trained in a two-week emergency preparedness course on how to manage natural disasters, mass shootings or pandemics.
-
Poor Heart Health Before Pregnancy Linked to Adverse Outcomes
A new study shines a spotlight on an important but often overlooked matter of the heart — optimizing cardiovascular health before getting pregnant.
-
In Cancer Treatment, Quality of Life Matters More and More
A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.
-
First Model to Predict Lifetime Risk of Heart Failure
A new Northwestern Medicine study has, for the first time, derived and validated a set of risk prediction models for lifetime risk of heart failure.
